Latest News & Features
Americas
Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated secrets and breached contract | Companies in dispute process and manufacture medical products derived from human placental tissue. 7 January 2025
Americas
Biotech walks away with another win as Fed Circ upholds PTAB decision | Labcorp’s attempt to overturn $373m verdict fails | Court finds Ravgen’s method for preserving DNA in blood samples not obvious. 7 January 2025
Careers
Two large teams leave Locke Lord following Troutman Pepper merger | Buchanan opens Chicago office with a large life sciences group | Shoosmiths adds team in London to expand brand-focused IP services. 7 January 2025
Careers
New partner brings technical background in computer science and more than a decade experience in patent litigation | Expertise in tech, engineering, chemical, and life sciences sectors. 7 January 2025
Americas
The Japanese pharma company files complaint against Lupin Pharmaceuticals | Suit alleges patent infringement over the company’s proposed generic version of a key ALS drug. 2 January 2025
Americas
Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler. 2 January 2025
Americas
Andrew Wells of HGF explores how the EU Clinical Trials Regulation is affecting lifecycle IP strategies, and offers guidance on protecting inventions arising during clinical development. 25 December 2024
Americas
In an incredibly competitive and complex landscape, intellectual property is a critical asset for pharmaceutical and biotech companies. 25 December 2024
Americas
Dispute stems from Amneal’s efforts to market generic version of Teva’s inhaler for treating asthma | Precedential decision could restrict how brand-name pharmaceutical companies use the Orange Book to extend market exclusivity. 24 December 2024
Americas
Massachusetts medical research company is awarded damages following a jury verdict that found a Japanese pharma had infringed on its patent | Patent relates to Duchenne muscular dystrophy treatment. 24 December 2024